Volume : 6, Issue : 3, March - 2017

LEVEL III AXILLARY LYMPH NODE DISSECTION IN BREAST CARCINOMA

Dr Arpan Chaturmohta, Dr Rajentankshali

Abstract :

<p>&nbsp;<span lang="EN-IN" style="text-align: justify; font-size: 14pt; line-height: 115%; font-family: &quot;Times New Roman&quot;, serif;">As the trend is towards conservative surgery for the east carcinoma, the necessity of the complete axillary dissection is being questioned much more today. In this study, we aimed to analyze the frequency of level III lymph node metastases and the contributing risk factors and occurrence of axillary arm odema post level III dissection. One hundred and four female, histopathologically proven east carcinoma patients underwent modified radical mastectomy and complete axillary dissection in the Department of Surgical Oncology, Gujarat Cancer &amp; Research Institute, Ahmedabad were included in the study. The level III specimen was sent separately to the pathological examination. Age, menopausal status, tumor location, histopathological type, grade, pathological T and N stage, estrogen (ER) and progesterone (PR) receptor status, multicentricity, total metastatic lymph nodes in level I+II, lymph node capsule invasion (N1b3, N2) were analyzed as the risk factors. Axillary arm oedema measurements were taken and followed for upto 4 months postoperatively.</span><span lang="EN-IN" style="text-align: justify;"> </span><span lang="EN-IN" style="text-align: justify; font-size: 14pt; line-height: 115%; font-family: &quot;Times New Roman&quot;, serif;">According to our results for appropriate staging and adequate local control we recommend complete axillary dissection including level III lymph nodes except for a selected group of patients as it helps in better oncological clearance, lesser recurrence rate and higher disease free survival rate</span></p> <p class="MsoNormal" style="text-align:justify"><span lang="EN-IN" style="font-size:14.0pt;line-height:115%;&#10;font-family:&quot;Times New Roman&quot;,serif"><o:p></o:p></span></p>